| NIDDK Welcomes Five New Members to Advisory
Secretary of Health and Human Services Michael O. Leavitt has
appointed five new members to the Advisory Council of the National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
the Institute announced today. NIDDK is part of the National Institutes
of Health (NIH) of the U.S. Department of Health and Human Services.
The NIH is the federal agency with primary responsibility for funding
and conducting biomedical research within the United States. NIDDK
Director, Allen M. Spiegel, M.D., welcomed the following members
at NIDDK’s February meeting:
Janice Lee Arnold, M.D., is a board certified urologist
with 15 years of practice in the Northern Virginia and Washington,
D.C., area. Dr. Arnold’s area of expertise is lower urinary
tract disorders involving the prostate and urinary bladder. She
is one of the area’s leading specialists in the treatment
of urinary incontinence and has worked tirelessly to raise awareness
and promote research funding of prostate cancer. She is an Executive
Board member of the Northern Virginia Medical Society and is on
the Board of Directors of the Virginia Division of the American
Cancer Society. She is currently serving as President of the National
Society of Women in Urology. Dr. Arnold joins the Kidney, Urologic,
and Hematologic Diseases (KUH) Subcommittee.
Janet O. Brown-Friday, R.N., M.S.N., M.P.H., is the Clinical
Manager of the Diabetes Clinical Trials Unit at the Albert Einstein
College of Medicine in the Bronx, New York. As Clinical Trials
Manager Ms. Brown-Friday is responsible for multiple NIH-funded
clinical trials and acts as supervisor of all clinical operations,
including oversight or submission of protocols to all Institutional
Review Boards (IRB), staff education and development, direct case
management of study volunteers, management of study data, development
of patient education materials, patient education, and manager
of clinical budget. From 1995 until 2002, Ms. Brown-Friday was
the Albert Einstein College of Medicine study coordinator and supervisor
for the Diabetes Prevention Program (DPP) and was a member of the
DPP national study group protocol development team. Ms. Brown-Friday
is currently serving as the study coordinator of the Diabetes Prevention
Program Outcomes Study (DPPOS) at Albert Einstein College of Medicine.
Ms. Brown-Friday is also a member of the National Diabetes Education
Program’s African American Workgroup and DPP Translation
Workgroup. She joins the Diabetes, Endocrinology, and Metabolic
Diseases (DEM) Subcommittee.
Jeffrey Scott Flier, M.D., is the George C. Reisman Professor
of Medicine at Harvard Medical School in Boston, Massachusetts.
He is also the Chief Academic Officer and Harvard Faculty Dean
for Academic Programs at Beth Israel Deaconess Medical Center in
Boston. Dr. Flier’s research interests include the study
of molecular biology of insulin action in health and disease, the
pathophysiology of obesity and weight regulation, the physiology
of leptin, and transgenic models of diabetes and obesity. From
1974 to 1978, Dr. Flier served as a Clinical Associate in the Diabetes
Branch of the National Institute of Arthritis, Metabolism, and
Digestive Diseases, the predecessor of the current NIDDK, in Bethesda,
Maryland. Dr. Flier is a member of the American Diabetes Association,
the Endocrine Society, and the Institute of Medicine of the National
Academy of Sciences. He joins the Diabetes, Endocrinology, and
Metabolic Diseases (DEM) Subcommittee.
William L. Henrich, M.D., is the Theodore E. Woodward Professor
and Chairman of the Department of Medicine at the University of
Maryland School of Medicine in Baltimore. He is also the Physician-in-Chief
of the University of Maryland Hospital in Baltimore. Dr. Henrich’s
research interests include hemodynamic stability during dialysis,
analgesic effects on the kidney, and the intrarenal renin-angiotensin
system. Dr. Henrich is a past and current NIH and NIDDK grantee
and has served as an NIH study section Chair, as well as an External
Review Committee Chair. He is an active member of the National
Kidney Foundation, the American Society of Nephrology, and the
American Heart Association. Dr. Henrich joins the Kidney, Urologic,
and Hematologic Diseases (KUH) Subcommittee.
Brian P. Monahan, M.D., FACP, is Associate Professor of
Medicine and Hematology/Oncology Division Director in the Department
of Medicine at the F. Edward Hebert School of Medicine, Uniformed
Services University of the Health Sciences, in Bethesda, Maryland.
As such, he serves as Program Director in Hematology and Medical
Oncology at the National Naval Medical Center in Bethesda. He is
the Chair of the Department of Defense Working Group on Cancer
Research and Policy at the United States Military Cancer Institute.
He is also Adjunct Assistant Professor at the University of Maryland
School of Nursing in Baltimore. His research interests include
translational research, graduate medical education in hematology
and medical oncology, phase I clinical trials of novel anti-cancer
agents, and malignancies of the gastrointestinal tract. Dr. Monahan
is a Captain in the United States Navy, and has distinguished himself
with more than 19 years of military service. He is a member of
the American Society of Clinical Oncology, American Society of
Hematology, American College of Physicians and the American Medical
Association. Dr. Monahan will serve as an Ex-Officio member of
the Advisory Council.
They will serve until 2008.
Established by law and charter, the NIDDK Advisory Council meets
three times annually to advise the NIDDK about its research portfolio.
The Council typically undertakes broad issues of science policy.
Members of the Advisory Council are drawn from the scientific and
lay communities, are appointed for 4-year terms, and represent
all areas within the Institute’s research mission. An important
role of the Council is to provide second-level peer review of grant
applications that have been scored by scientific review groups.
The Council members are an important liaison between the research
communities they represent and the NIDDK, which supports each community’s